Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine:: a prospective study

被引:221
作者
Adegbola, RA
Secka, O
Lahai, G
Lloyd-Evans, N
Njie, A
Usen, S
Oluwalana, C
Obaro, S
Weber, M
Corrah, T
Mulholland, K
McAdam, K
Greenwood, B
Milligan, PJM
机构
[1] MRC Labs, Banjul, Gambia
[2] Natl Hlth Lab, Banjul, Gambia
[3] Dept State Hlth, Banjul, Gambia
[4] Royal Childrens Hosp, Parkville, Vic 3052, Australia
[5] London Sch Hyg & Trop Med, Dept Infect Dis, London WC1, England
基金
英国医学研究理事会;
关键词
D O I
10.1016/S0140-6736(05)66788-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Routine immunisation of infants in The Gambia with a Haemophilus influenzae type b (Hib) polysaccharide-tetanus toxoid conjugate vaccine began in May, 1997. We investigated the effectiveness of the vaccine when delivered through the expanded programme on immunisation and the effect of national immunisation. on incidence of Hib disease. Methods Surveillance for Hib disease was maintained in the western half of The Gambia using standard methods with an emphasis on meningitis. We estimated vaccine efficacy using the case control method, and vaccine coverage and population denominators for incidence rates using a cluster sample survey. Prevalence of Hib carriage in a sample of 1-2-year old children attending health centres for vaccination was ascertained with oropharyngeal swabs plated onto antiserum agar. Findings Between May, 1997, and April, 2002, a total of 5984 children were examined for possible Hib infections. 49 children had Hib disease, 36 of whom had meningitis. The annual incidence rates of Hib meningitis before any use of the vaccine (1990-93) dropped from over 200 per 100 000 children aged younger than 1 year to none per 100 000 in 2002, and from 60 to no cases per 100 000 in children younger than 5 years. The prevalence of Hib carriage decreased from 12% to 0.25% (p<0.0001). Two doses of vaccine were needed for direct protection from Hib disease (vaccine efficacy 94%, 95% CI 62-99). Since most children received a protective dose after the age of greatest disease risk, indirect effects were important in reducing disease incidence. Interpretation The Gambian Hib immunisation programme reduced the occurrence of Hib disease despite irregular vaccine supply. The effect of the programme in The Gambia has important implications for the introduction of the vaccine into routine immunisation. programmes of other developing countries.
引用
收藏
页码:144 / 150
页数:7
相关论文
共 25 条
[1]   DECLINE OF CHILDHOOD HAEMOPHILUS-INFLUENZAE TYPE-B (HIB) DISEASE IN THE HIB VACCINE ERA [J].
ADAMS, WG ;
DEAVER, KA ;
COCHI, SL ;
PLIKAYTIS, BD ;
ZELL, ER ;
BROOME, CV ;
WENGER, JD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (02) :221-226
[2]   Haemophilus influenzae type b disease in the western region of the Gambia: Background surveillance for a vaccine efficacy trial [J].
Adegbola, RA ;
Mulholland, EK ;
Falade, AG ;
Secka, O ;
SargeNjai, R ;
Corrah, T ;
Palmer, A ;
Schneider, G ;
Greenwood, BM .
ANNALS OF TROPICAL PAEDIATRICS, 1996, 16 (02) :103-111
[3]   Vaccination with a Haemophilus influenzae type b conjugate vaccine reduces oropharyngeal carriage of H-influenzae type b among Gambian children [J].
Adegbola, RA ;
Mulholland, EK ;
Secka, O ;
Jaffar, S ;
Greenwood, BM .
JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (06) :1758-1761
[4]   Haemophilus influenzae type b meningitis in The Gambia after introduction of a conjugate vaccine [J].
Adegbola, RA ;
Usen, SO ;
Weber, M ;
Lloyd-Evans, N ;
Jobe, K ;
Mulholland, K ;
McAdam, KPWJ ;
Greenwood, BM ;
Milligan, PJM .
LANCET, 1999, 354 (9184) :1091-1092
[5]   INCREASE IN BACTEREMIC PNEUMOCOCCAL INFECTIONS IN CHILDREN [J].
BAER, M ;
VUENTO, R ;
VESIKARI, T .
LANCET, 1995, 345 (8950) :661-661
[6]   THE EPIDEMIOLOGY OF HAEMOPHILUS-INFLUENZAE MENINGITIS IN CHILDREN UNDER 5 YEARS OF AGE IN THE GAMBIA, WEST-AFRICA [J].
BIJLMER, HA ;
VANALPHEN, L ;
GREENWOOD, BM ;
BROWN, J ;
SCHNEIDER, G ;
HUGHES, A ;
MENON, A ;
ZANEN, HC ;
VALKENBURG, HA .
JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (06) :1210-1215
[7]  
BIJLMER HA, 1991, VACCINE S, V9, P5
[8]   COMPARATIVE IMMUNOGENICITY OF 4 HAEMOPHILUS-INFLUENZAE TYPE-B CONJUGATE VACCINES IN ALASKA NATIVE INFANTS [J].
BULKOW, LR ;
WAINWRIGHT, RB ;
LETSON, GW ;
CHANG, SJ ;
WARD, JI .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1993, 12 (06) :484-492
[9]  
COCHI SL, 1988, PEDIATRICS, V81, P166
[10]   Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial [J].
Cutts, FT ;
Zaman, SMA ;
Enwere, G ;
Jaffar, S ;
Levine, OS ;
Okoko, JB ;
Oluwalana, C ;
Vaughan, A ;
Obaro, SK ;
Leach, A ;
McAdam, KP ;
Biney, E ;
Saaka, M ;
Onwuchekwa, U ;
Yallop, F ;
Pierce, NF ;
Greenwood, BM ;
Adegbola, RA .
LANCET, 2005, 365 (9465) :1139-1146